The efficacy of topical recombinant interferon alpha 2B will be tested in a clinical trial to be held in eastern Cuba. This is intended to medically treat the recurrence of actinic keratosis.<br /> Dr. Orestes Marino, director of Ophthalmic surgical hospital Lucia Iñiguez clinical, of this city, told AIN that the product is a new implementation of the Center for Genetic Engineering and Biotechnology (ICGEB) in Havana.
Read More